GB0918782D0 - A protein as an adjuvant for a vaccine - Google Patents

A protein as an adjuvant for a vaccine

Info

Publication number
GB0918782D0
GB0918782D0 GBGB0918782.4A GB0918782A GB0918782D0 GB 0918782 D0 GB0918782 D0 GB 0918782D0 GB 0918782 A GB0918782 A GB 0918782A GB 0918782 D0 GB0918782 D0 GB 0918782D0
Authority
GB
United Kingdom
Prior art keywords
vaccine
adjuvant
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0918782.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
City St Georges University of London
Original Assignee
St Georges Hospital Medical School
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by St Georges Hospital Medical School filed Critical St Georges Hospital Medical School
Priority to GBGB0918782.4A priority Critical patent/GB0918782D0/en
Publication of GB0918782D0 publication Critical patent/GB0918782D0/en
Priority to PCT/GB2010/001976 priority patent/WO2011051657A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55583—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GBGB0918782.4A 2009-10-26 2009-10-26 A protein as an adjuvant for a vaccine Ceased GB0918782D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0918782.4A GB0918782D0 (en) 2009-10-26 2009-10-26 A protein as an adjuvant for a vaccine
PCT/GB2010/001976 WO2011051657A1 (en) 2009-10-26 2010-10-25 Thymic stromal lymphopoietin as an adjuvant for a vaccine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0918782.4A GB0918782D0 (en) 2009-10-26 2009-10-26 A protein as an adjuvant for a vaccine

Publications (1)

Publication Number Publication Date
GB0918782D0 true GB0918782D0 (en) 2009-12-09

Family

ID=41426741

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0918782.4A Ceased GB0918782D0 (en) 2009-10-26 2009-10-26 A protein as an adjuvant for a vaccine

Country Status (2)

Country Link
GB (1) GB0918782D0 (en)
WO (1) WO2011051657A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160052985A1 (en) * 2013-04-04 2016-02-25 Ieo - Istituto Europeo Di Oncologia Srl Thymic stromal lymphopoietin fragments and uses thereof
JP2019094262A (en) * 2016-03-31 2019-06-20 国立大学法人東北大学 Low molecular weight compound adjuvant and vaccine containing the same
CN114767847B (en) * 2022-06-22 2022-09-23 深圳大学 New crown recombinant protein vaccine adjuvant and its application

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2357538A1 (en) 1989-03-21 1990-10-04 Wisconsin Alumni Research Foundation Expression of exogenous polynucleotide sequences in a vertebrate
US5279833A (en) 1990-04-04 1994-01-18 Yale University Liposomal transfection of nucleic acids into animal cells
US5283185A (en) 1991-08-28 1994-02-01 University Of Tennessee Research Corporation Method for delivering nucleic acids into cells
WO1993018759A1 (en) 1992-03-20 1993-09-30 Baylor College Of Medicine A dna transporter system and method of use
WO1993019768A1 (en) 1992-04-03 1993-10-14 The Regents Of The University Of California Self-assembling polynucleotide delivery system
WO1994022473A1 (en) * 1993-04-01 1994-10-13 University Of Washington Use of interleukin 7 to improve vaccine potency
US5651981A (en) 1994-03-29 1997-07-29 Northwestern University Cationic phospholipids for transfection
US5527928A (en) 1994-09-30 1996-06-18 Nantz; Michael H. Cationic transport reagents
US7288633B2 (en) * 2001-07-23 2007-10-30 Immunex Corporation Modified human thymic stromal lymphopoietin
GB2410497B (en) 2002-09-27 2006-11-22 Powderject Res Ltd Nucleic acid coated particles
AU2004257781B2 (en) * 2003-07-18 2009-07-16 Merck Sharp & Dohme Corp. Treatment and diagnosis of neoplasms using Thymic Stromal Lymphopoietin
US20050249712A1 (en) * 2004-03-23 2005-11-10 The Government Of The Usa As Represented By The Secretary Of The Dept. Of Health & Human Services Methods for use of TSLP and agonists and antagonists thereof
WO2009036568A1 (en) * 2007-09-19 2009-03-26 University Health Network Methods and compositions for treating tumors and viral infections

Also Published As

Publication number Publication date
WO2011051657A1 (en) 2011-05-05

Similar Documents

Publication Publication Date Title
ZA201109164B (en) Vaccine
GB0905570D0 (en) Combined vaccines
GB0822001D0 (en) Vaccine
GB201006165D0 (en) Vaccine
GB0810710D0 (en) Vaccine
IL214257A0 (en) Peptides for vaccine
GB0816284D0 (en) Vaccine
GB0907935D0 (en) Vaccines
GB0816447D0 (en) Vaccine
IL216102A0 (en) Combined measles-malaria vaccine
GB201000522D0 (en) Vaccine
ZA201201387B (en) Bovine herpesvirus vaccine
GB0918782D0 (en) A protein as an adjuvant for a vaccine
IL217194A0 (en) Vaccine
GB0902344D0 (en) Peptides for vaccine
GB0917871D0 (en) Peptides for vaccine
GB0902345D0 (en) Peptides for vaccine
GB0901928D0 (en) Peptides for vaccine
GB0914545D0 (en) Vaccine
AU2014201356B2 (en) Combined measles-malaria vaccine
GB201001624D0 (en) Peptides for vaccine
ZA201107971B (en) Combined measles-malaria vaccine
GB0909146D0 (en) Vaccines
GB0909144D0 (en) Vaccines
GB0909147D0 (en) Vaccines

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)